Carmit Nadri-Shay
Consigliere Generale presso ADVAXIS, INC.
Posizioni attive di Carmit Nadri-Shay
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADVAXIS, INC. | Consigliere Generale | - | - |
| AYALA PHARMACEUTICALS, INC. | Consigliere Generale | 01/01/2018 | - |
Storia della carriera di Carmit Nadri-Shay
Precedenti posizioni note di Carmit Nadri-Shay
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Consigliere Generale | - | - |
| KAMADA LTD. | Consigliere Generale | - | - |
Formazione di Carmit Nadri-Shay
| Ben-Gurion University of the Negev | Doctorate Degree |
Statistiche
Distribuzione geografica
| Israele | 5 |
| Stati Uniti | 2 |
Posizioni
| General Counsel | 4 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KAMADA LTD. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Aziende private | 2 |
|---|---|
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Borsa valori
- Insiders
- Carmit Nadri-Shay
- Esperienza
